Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.
暂无分享,去创建一个
G. Chrousos | J. Schulkin | M. Champoux | S. Suomi | J. Higley | C. Bastard | R. Hamoudi | M. Callanan | R. Rimokh | C. Contoreggi | A. Atkinson | K. Rice | P. Gold | S. Mccann | S. Listwak | G P Chrousos | P W Gold | J Schulkin | K C Rice | E. Webster | K. Habib | K. Weld | J. Pushkas | A. J. Atkinson | S J Suomi | J. Sotto | C Contoreggi | M Champoux | J D Higley | K E Habib | K P Weld | J Pushkas | S Listwak | E L Webster | A J Atkinson | S M McCann | P. Mossuz | S. Duley | Kenner C. Rice | G. Klobeck | K. P. Weld | Martin J. Dyer | Dominique Leroux | Kenner C. Rice | Elizabeth L. Webster | Dominique Leroux | Stephen J. Suomi | K. Habib | Samuel Listwak | Arthur J. Atkinson | Jay Schulkin | Carlo Contoreggi | Samuel M. McCann | Mary B. Callanan | Pascal Mossuz | Christian Bastard | Martin J. Dyer | Gustav Klobeck | Ruth Rimokh | Jean Jacques Sotto | Dominique Leroux
[1] Peter J. Munson,et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Mccann,et al. Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. D. McGaugh,et al. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala , 1999, Biological Psychiatry.
[4] T. Insel,et al. Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain , 1999, The Journal of comparative neurology.
[5] F. Holsboer,et al. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. , 1999, Journal of psychiatric research.
[6] G. Chrousos. Reproductive placental corticotropin-releasing hormone and its clinical implications. , 1999, American journal of obstetrics and gynecology.
[7] S. Maier,et al. The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress * , 1998 .
[8] J. Ellison. Antidepressant‐Induced Sexual Dysfunction: Review, Classification, and Suggestions for Treatment , 1998, Harvard review of psychiatry.
[9] M. Hongo,et al. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.
[10] D. Torpy,et al. Corticotropin‐Releasing Hormone and Inflammation , 1998, Annals of the New York Academy of Sciences.
[11] G. Chrousos,et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. , 1998, Endocrinology.
[12] G. Chrousos,et al. Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects. , 1998, Endocrinology.
[13] J. D. McGaugh,et al. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Corman,et al. Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist. , 1997, Journal of medicinal chemistry.
[15] G. Chrousos,et al. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.
[16] T. Lovenberg,et al. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. , 1996, Molecular psychiatry.
[17] T. Bártfai,et al. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. , 1996, European journal of pharmacology.
[18] S. Bernasconi,et al. Dose-dependent inhibition of growth hormone (GH)-releasing hormone-induced GH release by corticotropin-releasing hormone in prepubertal children. , 1996, The Journal of clinical endocrinology and metabolism.
[19] M. W. Andrews,et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[21] L. Chen,et al. The role of amygdala norepinephrine in memory formation: involvement in the memory enhancing effect of peripheral epinephrine. , 1995, The Chinese journal of physiology.
[22] J. Rybakowski,et al. Depression and T lymphocytes in patients with irritable bowel syndrome. , 1993, Journal of affective disorders.
[23] K. Lyson,et al. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. D. De Bellis,et al. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. , 1993, The American journal of psychiatry.
[25] S. Moller,et al. Naloxone stimulation test in women with hypothalamic amenorrhea: a preliminary report. , 2009, Experimental and clinical endocrinology.
[26] M. Linnoila,et al. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys , 1992, Biological Psychiatry.
[27] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[28] R. Hirsch,et al. Peers as primary attachment sources in yearling rhesus monkeys (Macaca mulatta) , 1992 .
[29] D. Jezova,et al. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. , 1991, Neuroendocrinology.
[30] P. Gold,et al. Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey , 1991, Neuropeptides.
[31] T. Laatikainen. Corticotropin-releasing hormone and opioid peptides in reproduction and stress. , 1991, Annals of medicine.
[32] A. Tofani,et al. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. , 1990, The Journal of clinical endocrinology and metabolism.
[33] T. Insel. Models of Mental Disorders: A New Comparative Psychiatry , 1990 .
[34] S. Vellucci. Primate social behavior--anxiety or depression? , 1990, Pharmacology & therapeutics.
[35] M. Smith,et al. Corticotropin-releasing hormone: from endocrinology to psychobiology. , 1989, Hormone research.
[36] Randall B. Smith,et al. Compartmental Model Analysis in Pharmacokinetics , 1987, Journal of clinical pharmacology.
[37] J. Calabrese,et al. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. , 1987, Advances in biochemical psychopharmacology.
[38] D. Murphy,et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. , 1986, Clinical chemistry.
[39] Kalin Nh. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys. , 1985 .
[40] G. Chrousos,et al. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. , 1984, The New England journal of medicine.